Inventory

6 Months Ended

Jun. 30, 2017

Inventory Disclosure [Abstract]

Inventory

(4) Inventory

The Company capitalizes its purchases of saleable inventory of Vascepa from suppliers that have been qualified by the FDA. Inventories as of June 30, 2017 and December 31, 2016 consist of the following:

In thousands	June 30, 2017		December 31, 2016
Raw materials	$	7,345	$	4,430
Work in process		10,099		10,716
Finished goods		7,370		5,361
Total inventory	$	24,814	$	20,507